The company expects to secure Ethics Committee approval by end of November which would allow first-in-human CarpX clinical series in New Zealand in December. Esocheck was highlighted as one of the year’s significant advances in cancer prevention by the National Cancer Institute. They expect to submit EsoCheck CCD for 510(k) clearance by end of November. They have engaged a major investment bank to explore potential strategic partnerships including acquisition of PortIO. I continue to buy at these levels and look forward to multi-bagger returns in '19. GL.
Recent PAVM News
- American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test • PR Newswire (US) • 09/24/2024 12:01:00 PM
- PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements • PR Newswire (US) • 09/16/2024 08:30:00 PM
- Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress • PR Newswire (US) • 09/10/2024 11:56:00 AM
- Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health • PR Newswire (US) • 09/03/2024 11:51:00 AM
- Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer • PR Newswire (US) • 08/20/2024 12:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:18:18 PM
- The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer • PR Newswire (US) • 08/13/2024 12:16:00 PM
- PAVmed Provides Business Update and Second Quarter 2024 Financial Results • PR Newswire (US) • 08/13/2024 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:08:39 PM
- Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results • PR Newswire (US) • 08/12/2024 12:07:00 PM
- Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event • PR Newswire (US) • 08/08/2024 12:31:00 PM
- Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing • PR Newswire (US) • 08/06/2024 12:15:00 PM
- Lucid Diagnostics to Participate in Upcoming Investor Conferences • PR Newswire (US) • 08/05/2024 12:15:00 PM
- PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024 • PR Newswire (US) • 07/30/2024 12:15:00 PM
- Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024 • PR Newswire (US) • 07/29/2024 12:15:00 PM
- Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume • PR Newswire (US) • 07/23/2024 12:01:00 PM
- Lucid Diagnostics Launches New Corporate Website • PR Newswire (US) • 07/11/2024 12:31:00 PM
- Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population • PR Newswire (US) • 07/02/2024 11:55:00 AM
- PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute • PR Newswire (US) • 06/13/2024 11:58:00 AM
- 4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing • PR Newswire (US) • 06/12/2024 12:05:00 PM
- PAVmed Provides Business Update and First Quarter 2024 Financial Results • PR Newswire (US) • 05/14/2024 12:43:00 AM
- Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results • PR Newswire (US) • 05/13/2024 12:00:00 PM
- Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall • PR Newswire (US) • 05/09/2024 11:49:00 AM
- Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors • PR Newswire (US) • 05/07/2024 11:39:00 AM
- PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 • PR Newswire (US) • 05/03/2024 12:35:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM